HomeAI · summaries
Storia in 5 fonti
Pfizer to make $2.5B in new cost cuts
Pfizer’s yearslong cost-cutting effort is continuing apace, and it disclosed a $4.3 billion write-down tied to a Phase 3 trial miss for sigvotatug vedotin.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Pfizer expands multibillion-dollar cost-cutting plan
Hatched three years ago, the restructuring is now expected to deliver $1 billion in new cost reductions and save Pfizer another $1.5 billion by streamlining drug production.
- ·
endpoints.news
Pfizer to make $2.5B in new cost cuts
Pfizer’s yearslong cost-cutting effort is continuing apace, and it disclosed a $4.3 billion write-down tied to a Phase 3 trial miss for sigvotatug vedotin.
